Literature DB >> 14724254

Suppression of p75NTR does not promote regeneration of injured spinal cord in mice.

Xing-Yun Song1, Jin-hua Zhong, Xin Wang, Xin-Fu Zhou.   

Abstract

The neurotrophin receptor p75NTR is the coreceptor for Nogo receptor, mediating growth cone collapse in vitro by MAG, myelin oligodendrocyte glycoprotein (Omgp), and Nogo. Whether p75NTR plays any role in the failure of nerve regeneration in vivo is not known. Immunohistochemical data showed that p75NTR was expressed in only a very small subset of ascending sensory axons but not in any corticospinal axons in the dorsal column of either normal or injured spinal cord. Using p75NTR-deficient mice, we showed that the depletion of the functional p75NTR did not promote the regeneration of the descending corticospinal tract and ascending sensory neurons in the spinal cord 2 weeks after spinal cord injury. Local administration of p75NTR-Fc fusion molecule, the dominant-negative receptor to block the function of neurite outgrowth inhibitors, did not improve regeneration of ascending sensory neurons in the injured spinal cord. Our results suggest that p75NTR may not be a critical molecule mediating the function of myelin-associated inhibitory factors in vivo.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14724254      PMCID: PMC6730005          DOI: 10.1523/JNEUROSCI.4281-03.2004

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  30 in total

1.  Ameliorative Effects of p75NTR-ED-Fc on Axonal Regeneration and Functional Recovery in Spinal Cord-Injured Rats.

Authors:  Yong-Tang Wang; Xiu-Min Lu; Feng Zhu; Peng Huang; Ying Yu; Zai-Yun Long; Ya-Min Wu
Journal:  Mol Neurobiol       Date:  2014-11-15       Impact factor: 5.590

Review 2.  Multiple signals regulate axon regeneration through the Nogo receptor complex.

Authors:  Toshihide Yamashita; Masashi Fujitani; Satoru Yamagishi; Katsuhiko Hata; Fumiaki Mimura
Journal:  Mol Neurobiol       Date:  2005-10       Impact factor: 5.590

3.  The Nogo-66 receptor homolog NgR2 is a sialic acid-dependent receptor selective for myelin-associated glycoprotein.

Authors:  Karthik Venkatesh; Onanong Chivatakarn; Hakjoo Lee; Pushkar S Joshi; David B Kantor; Barbara A Newman; Rose Mage; Christoph Rader; Roman J Giger
Journal:  J Neurosci       Date:  2005-01-26       Impact factor: 6.167

Review 4.  Molecular targets in spinal cord injury.

Authors:  Stefan Klussmann; Ana Martin-Villalba
Journal:  J Mol Med (Berl)       Date:  2005-08-02       Impact factor: 4.599

Review 5.  Glial inhibition of CNS axon regeneration.

Authors:  Glenn Yiu; Zhigang He
Journal:  Nat Rev Neurosci       Date:  2006-08       Impact factor: 34.870

6.  Mice lacking the p75 receptor fail to acquire a normal complement of taste buds and geniculate ganglion neurons by adulthood.

Authors:  Robin F Krimm
Journal:  Anat Rec A Discov Mol Cell Evol Biol       Date:  2006-12

7.  Plexina2 and CRMP2 Signaling Complex Is Activated by Nogo-A-Liganded Ngr1 to Restrict Corticospinal Axon Sprouting after Trauma.

Authors:  Yuichi Sekine; Percy T Algarate; William B J Cafferty; Stephen M Strittmatter
Journal:  J Neurosci       Date:  2019-02-25       Impact factor: 6.167

8.  Effects of PTEN and Nogo Codeletion on Corticospinal Axon Sprouting and Regeneration in Mice.

Authors:  Cédric G Geoffroy; Ariana O Lorenzana; Jeffrey P Kwan; Kyle Lin; Omeed Ghassemi; Andrew Ma; Nuo Xu; Daniel Creger; Kai Liu; Zhigang He; Binhai Zheng
Journal:  J Neurosci       Date:  2015-04-22       Impact factor: 6.167

Review 9.  Mechanisms of CNS myelin inhibition: evidence for distinct and neuronal cell type specific receptor systems.

Authors:  Roman J Giger; Karthik Venkatesh; Onanong Chivatakarn; Stephen J Raiker; Laurie Robak; Thomas Hofer; Hakjoo Lee; Christoph Rader
Journal:  Restor Neurol Neurosci       Date:  2008       Impact factor: 2.406

10.  Strategies for regenerating injured axons after spinal cord injury - insights from brain development.

Authors:  Masaki Ueno; Toshihide Yamashita
Journal:  Biologics       Date:  2008-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.